Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects

Clinical trial NCT05256017 · COMPLETED

Trial details

NCT number: NCT05256017
Sponsor: Drugs for Neglected Diseases
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Trypanosomiasis, African Trypanosoma Brucei Gambiense; Infection Sleeping Sickness

Start date: 2021-12-30
Primary completion: 2023-08-03
Enrollment: 1208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.